FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

2946411000001105: Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) 180 dose (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25922101000001115 Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) 180 dose (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
49340001000001118 Nasobec Hayfever 50micrograms/dose nasal spray (Teva UK Ltd) 180 dose en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) 180 dose Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) 180 dose Is a Beclometasone 50micrograms/actuation nasal spray 180 dose true Inferred relationship Existential restriction modifier
Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) 180 dose Is pack of Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) false Inferred relationship Existential restriction modifier
Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) 180 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) 180 dose Has active ingredient Beclometasone dipropionate false Inferred relationship Existential restriction modifier
Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) 180 dose Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) 180 dose Has excipient Benzalkonium chloride false Inferred relationship Existential restriction modifier
Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) 180 dose Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) 180 dose Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) 180 dose Legal category Pharmacy medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) 180 dose VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) 180 dose VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) 180 dose Has manufactured dose form Spray dose form false Inferred relationship Existential restriction modifier
Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) 180 dose Has AMP Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) true Inferred relationship Existential restriction modifier
Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) 180 dose Has specific active ingredient Beclometasone dipropionate true Inferred relationship Existential restriction modifier
Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) 180 dose Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier
Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) 180 dose Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Nasobec Hayfever 50micrograms/actuation nasal spray (IVAX Pharmaceuticals UK Ltd) 180 dose Discontinued indicator Re-marketed true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start